Raymond James downgrades Xponential Fitness stock rating on Club Pilates weakness

Xponential reported an adjusted Q4 loss of $0.91/sh vs. a forecasted -$0.03, and the stock is down 31% YTD, trading at $5.67 (52-week high $11.14). Raymond James downgraded XPOF to Market Perform and removed its price target, estimating 2026 adjusted EBITDA of $107M (implying ~7x) while the company’s current EV/EBITDA is 6.55x. The company finalized a $17M FTC settlement over franchising disclosures, and activist shareholder Voss Capital is pressing the board to explore strategic alternatives including a sale of Club Pilates. Guggenheim cut its price target from $12 to $10 but maintained a Buy rating.

Analysis

The company is operating under a multi-layered value trap: weak unit economics in a franchised, membership-driven model plus an ongoing governance/regulatory overhang compresses buyer universe and forces any strategic outcome to be priced for execution risk rather than brand value. Franchise systems live and die on new-unit economics and churn — incremental increases in disclosure, legal costs or lease burdens reduce the NPV of franchise cash flows more than headline revenue misses, so small adverse shifts in unit economics cascade into outsized EBITDA downside over 12–24 months.

An activist/strategic-process path is the most probable catalyst in the next 3–9 months, but it creates asymmetric outcomes: a portfolio buyer or roll-up consolidator could pay a premium for system franchised revenue if they can credibly fix unit-level CAC and churn, while financial buyers will demand steep discounts to reserve for legal/legacy liabilities. That bifurcation means near-term upside is binary and takeover bid timing is the dominant source of volatility — absent a credible operational turnaround cadence, buyers will value certainty (cash, divestitures) over growth.

Second-order winners: firms that provide low-capex boutique fitness franchises or outsourced member acquisition services stand to gain if consolidation reduces the target’s marketing reach; lenders and covenant-heavy debt holders benefit from faster deleveraging if management sells a clean asset (brand) versus trying to fix system-wide economics. Watch three measurable inputs over the next two quarters — unit openings/closures, franchisee renewal rates, and marketing CAC — as the data points that will determine whether the market assigns a liquidation/process multiple or a normalized-growth multiple.

Key Decisions for Investors

• Short XPOF equity sized 1–2% of NAV with a 6–12 month horizon. Rationale: price-in a strategic sale at a steep discount + continued EBITDA erosion. Target downside 40–60%; tactical stop at 20–25% adverse move to cap drawdown.
• Buy a defined-risk 3–6 month put spread on XPOF (sell higher strike) to capture near-term downside while limiting premium outlay. Structure for ~3:1 potential payoff vs cost assuming a material announcement (sale process failure or further margin deterioration); theta decay is manageable at these tenors.
• Buy a small position (0.5–1% NAV) in 12–18 month deep OTM call options as a low-cost binary play on a strategic acquisition at a premium or operational turnaround. Upside is asymmetric if an industry consolidator values the brand; cap the allocation since this is a long-shot recovery scenario.
• Event-driven pair: if a formal sale process is announced, switch to long equity exposure hedged with shorter-dated puts to capture takeover premium while protecting against deal failure. Reduce hedge once a signed LOI is filed; target capture of 30–50% upside vs limited realized downside from hedges.